All Sauce from Weekly Sauce:

In a finding that suggests Ozempic and Wegovy have powers that extend beyond weight loss, a new study finds the medications might also lower people’s risk of opioid overdose. People with type 2 diabetes prescribed semaglutide (Ozempic, Wegovy) had a significantly lower risk of an opioid OD than patients taking any of eight other diabetic…  read on >  read on >

During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced tough questions over the company’s high prices for its blockbuster drugs Ozempic and Wegovy. While testifying before the Senate Committee on Health, Education, Labor and Pensions, Jørgensen shifted the blame for those prices to pharmacy benefits managers (PBMs),…  read on >  read on >

Only 1 in every 4 U.S. adults struggling with schizophrenia receive “minimally adequate treatment,” new data shows. Many of these patients also struggle with other mental health issues, such as substance abuse or depression, and they are further challenged by social and economic hardship, according to the new report. The data comes from the U.S.…  read on >  read on >

Two key symptoms that can arise soon after a diagnosis of multiple sclerosis (MS) could predict how swiftly the illness will progress and suggest best treatment options, new research shows. The two symptoms — blurred vision and sphincter dysfunction of the bladder and/or bowel — can arise in some, but not all, patients early in…  read on >  read on >

A non-drug nasal spray could theoretically help stop the spread of respiratory viruses like the flu and COVID-19 better than wearing a mask, a new study suggests. The spray uses ingredients that are medically inactive to trap germs in the nose before they can infect a person, researchers said. “We developed a drug-free formulation using…  read on >  read on >